Skip to main content
Clinical Trials/EUCTR2012-004546-15-FR
EUCTR2012-004546-15-FR
Active, not recruiting
Phase 1

Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up - Unwanted events in naive pediatric population treated by antipsychotic

CHU de Nice0 sites340 target enrollmentJune 19, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
severe behavioral disorders in mental retardation, autistic syndromesschizophrenia psychosis
Sponsor
CHU de Nice
Enrollment
340
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2013
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female patients
  • 6 •In whom antipsychotic treatment is indicated
  • Who have never been treated with antipsychotic medication (other than metoclopramide (Primperan®) for pediatric indications).
  • \- Receiving an antipsychotic for less than 15 days
  • \- Without history of exhibition in an antipsychotic or with a history of grip of antipsychotic of less than three consecutive months interrupted for more than six months before the inclusion
  • \- Hospitalized ( e ) in full\-time or day department, or seen ambulatory
  • \- Obtaining of the lit consent, the patient and his parents or the legal person in charge
  • \- Obtaining of the consent lit by the patient become major during the follow\-up
  • \- Membership in a national insurance scheme
  • Are the trial subjects under 18? yes

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials